drug · antibody
vamikibart
Phase 3updated 6mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying vamikibart
- phase2A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
- phase3Vamikibart in Participants With Uveitic Macular Edema
- phase3A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
- phase2A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema
News(1)
- Roche sets sights on FDA approval decision of July 2027 with updated eye drug dataOne year on from a mixed phase 3 readout, Roche has shared updated data from eye disease trials that could support FDA approval by July.fiercebiotech · 1mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that